Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Cytopathology : Official Journal of the British Society for Clinical Cytology|March 1, 2022
The role of cytology in the investigation and management of pancreatobiliary lesions with a transition towards a standardised reporting system: An institutional perspectiveMatthew Hanks, Stephen Ryder, Abed Zaitoun
British Journal of Hospital Medicine (London, England : 2005)|August 25, 2021
How to interpret and manage abnormal liver blood test results in older peopleMohsan Subhani, Abhishek Sheth, Bilal Ahmad, et al.
BJGP Open|July 6, 2021
Engagement with community liver disease management across the UK: a cross-sectional surveyHelen Jarvis, Jonathan Worsfold, Vanessa Hebditch, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 22, 2021
Does Advice Based on Biomarkers of Liver Injury or Non-Invasive Tests of Liver Fibrosis Impact High-Risk Drinking Behaviour: A Systematic Review With Meta-analysisMohsan Subhani, Holly Knight, Stephen Ryder, et al.
EMBO Reports|January 8, 2004
Distinct molecular phenotypes in bovine prion diseasesAnne-Gaëlle Biacabe, Jean-Louis Laplanche, Stephen Ryder, et al.
BJGP Open|September 18, 2024
Increasing engagement with liver disease management across the UK: a follow-up cross-sectional surveyHelen Jarvis, Charlotte Berry, Jonathan Worsfold, et al.
British Journal of Community Nursing|December 26, 2025
The effects of multimedia education tools on patients' health knowledgeKathryn Jack, Ultan Allen, Philippa Matthews, et al.
Journal of Hepatology|November 28, 2017
Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitisEwan H Forrest, Stephen R Atkinson, Paul Richardson, et al.
Family Practice|May 15, 2009
Health outcomes following liver function testing in primary care: a retrospective cohort studyDavid J McLernon, Peter T Donnan, Stephen Ryder, et al.
BMC Health Services Research|April 18, 2007
Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE)Peter T Donnan, David McLernon, Douglas Steinke, et al.
Pageof 3